Literature DB >> 10981961

Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling.

J F Purton1, R L Boyd, T J Cole, D I Godfrey.   

Abstract

Glucocorticoids are believed to play a role in T cell development and selection, although their precise function is controversial. Glucocorticoid receptor (GR)-deficient mice were used to directly investigate this problem. GR-deficient thymocytes were resistant to dexamethasone-mediated apoptosis, confirming the absence of glucocorticoid responsiveness. An absence of GR signaling had no impact on thymocyte development either in vivo or in vitro. T cell differentiation, including positive selection, was normal as assessed by normal development of CD4+CD8+, alphabetaTCR+CD4+, and alphabetaTCR+CD8+ thymocytes. Negative selection, mediated by the superantigen staphylococcal enterotoxin B (SEB), or anti-CD3/CD28, was also normal in the absence of GR signaling. In contrast to earlier reports, these data demonstrate that GR signaling is not essential for intrathymic T cell development or selection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981961     DOI: 10.1016/s1074-7613(00)00018-2

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  17 in total

1.  Induction of thymocyte positive selection does not convey immediate resistance to negative selection.

Authors:  Katherine J Hare; Judit Pongracz; Eric J Jenkinson; Graham Anderson
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

Review 2.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

3.  Enhanced glucocorticoid receptor signaling in T cells impacts thymocyte apoptosis and adaptive immune responses.

Authors:  Jens van den Brandt; Fred Lühder; Kirsty G McPherson; Katrien L de Graaf; Denise Tischner; Stefan Wiehr; Thomas Herrmann; Robert Weissert; Ralf Gold; Holger M Reichardt
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

Review 4.  Control of early stages in invariant natural killer T-cell development.

Authors:  Taishan Hu; Idoia Gimferrer; José Alberola-Ila
Journal:  Immunology       Date:  2011-06-30       Impact factor: 7.397

Review 5.  Glucocorticoids in T cell development, differentiation and function.

Authors:  Matthew D Taves; Jonathan D Ashwell
Journal:  Nat Rev Immunol       Date:  2020-11-04       Impact factor: 53.106

6.  Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells.

Authors:  Tim Thomas; Lynn M Corcoran; Raffi Gugasyan; Mathew P Dixon; Thomas Brodnicki; Stephen L Nutt; Donald Metcalf; Anne K Voss
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

Review 7.  Glucocorticoids in T cell apoptosis and function.

Authors:  M J Herold; K G McPherson; H M Reichardt
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

Review 8.  Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity.

Authors:  María Emilia Solano; Megan C Holmes; Paul R Mittelstadt; Karen E Chapman; Eva Tolosa
Journal:  Semin Immunopathol       Date:  2016-07-28       Impact factor: 9.623

9.  Increased p300 expression inhibits glucocorticoid receptor-T-cell receptor antagonism but does not affect thymocyte positive selection.

Authors:  Cheng-Tai Yu; Ming-Hsien Lin Feng; Hsiu-ming Shih; Ming-Zong Lai
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  CD8 lineage-specific regulation of interleukin-7 receptor expression by the transcriptional repressor Gfi1.

Authors:  Davinna L Ligons; Ceren Tuncer; Brett A Linowes; Izzet Mehmet Akcay; Sema Kurtulus; Emre Deniz; Belkis Atasever Arslan; Safak Isil Cevik; Hilary R Keller; Megan A Luckey; Lionel Feigenbaum; Tarik Möröy; Tulin Ersahin; Rengul Atalay; Batu Erman; Jung-Hyun Park
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.